PHILADELPHIA, PA, September 04, 2013 /24-7PressRelease/
, a compound pharmacy, has championed efforts to call attention to the erroneous decision of TRICARE leaders to cut coverage of specialty prescriptions. After the announcement that TRICARE, the insurance program offered to military personnel and their families, would no longer cover compounded medications, countless individuals contacted the organization and their local representatives to fight back. Now, according to an article
published by Military Times, the decision has been delayed due to a reevaluation of the situation.
Compounded medications are essential for individuals who have allergies or who need prescriptions in forms that are not mass produced. When a patient has an allergy to an ingredient in a medication, for example, a doctor will write a prescription for this medication and specify that it needs to be developed without the ingredient that will cause the patient harm. Compound pharmacies then create the medication in accordance with the specifications supplied by the doctor.
The issue that has been raised is that many of the ingredients used by compound pharmacies are not approved by the Food and Drug Administration--but the truth is that these are not ingredients that require approval to be sold. As such, stopping coverage of compounded medications will not necessarily improve the safety or health of military families. In fact, this will cut countless people off from the medications that are allowing them to live to the highest quality of life possible, as financial limitations will certainly prevent many individuals from filling their prescriptions if coverage is revoked.
A representative from QmedRx states: "Ultimately, it is a monumental mistake to stop coverage of compounded medications through TRICARE. Many people rely on compounded pharmaceuticals to function, as they cannot take the mass produced version of a drug due to allergies and other issues. By stopping coverage, decision makers will cause a great deal of harm to many military families--which is the exact opposite of what the TRICARE program was designed to do. We are happy to see that lawmakers are taking a second look at this issue, as it is surely one that impacts a wide range of individuals. We hope that the decision will be overturned and TRICARE will continue to cover compounded medications."
The article cites a press release published by TRICARE: "We are working to ensure both excellent and safe care for our beneficiaries and clear communication with our providers and beneficiaries."
Coverage of compounded medications will continue for six more months, so the professionals at QmedRx urge individuals to keep calling and voicing their support of TRICARE coverage until a final decision is made.
A compound and specialty pharmacy, QmedRx
provides patients with custom pharmaceuticals to meet their individual needs. Founded in 1990, the organization serves to provide access to prescription drugs to patients who cannot take the mass produced version of these pharmaceuticals due to allergies and other complications. Licensed in 48 states, the team that leads this company partners with doctors nationwide to ensure that each prescription is made to the specifications of the prescribing healthcare professional. Aside from general compounding, the professionals at this pharmacy specialize in transdermal scar and pain relief, wound care, sinus care, podiatry, nutrition, and Lyme disease.